Logan Latania K, Hujer Andrea M, Marshall Steven H, Domitrovic T Nicholas, Rudin Susan D, Zheng Xiaotian, Qureshi Nadia K, Hayden Mary K, Scaggs Felicia A, Karadkhele Anand, Bonomo Robert A
Department of Pediatrics, Rush University Medical Center, Chicago, Illinois, USA Research Service, Louis Stokes Cleveland Department of Veterans Affairs Medical Center, Case Western Reserve School of Medicine, Cleveland, Ohio, USA
Research Service, Louis Stokes Cleveland Department of Veterans Affairs Medical Center, Case Western Reserve School of Medicine, Cleveland, Ohio, USA Department of Medicine, Case Western Reserve School of Medicine, Cleveland, Ohio, USA.
Antimicrob Agents Chemother. 2016 May 23;60(6):3462-9. doi: 10.1128/AAC.00098-16. Print 2016 Jun.
Multidrug-resistant (MDR) Enterobacteriaceae infections are increasing in U.S. children; however, there is a paucity of multicentered analyses of antibiotic resistance genes responsible for MDR phenotypes among pediatric Enterobacteriaceae isolates. In this study, 225 isolates phenotypically identified as extended-spectrum β-lactamase (ESBL) or carbapenemase producers, recovered from children ages 0 to 18 years hospitalized between January 2011 and April 2015 at three Chicago area hospitals, were analyzed. We used DNA microarray platforms to detect ESBL, plasmid-mediated AmpC (pAmpC), and carbapenemase type β-lactamase (bla) genes. Repetitive-sequence-based PCR and multilocus sequence typing (MLST) were performed to assess isolate similarity. Plasmid replicon typing was conducted to classify plasmids. The median patient age was 4.2 years, 56% were female, and 44% presented in the outpatient setting. The majority (60.9%) of isolates were Escherichia coli and from urinary sources (69.8%). Of 225 isolates exhibiting ESBL- or carbapenemase-producing phenotypes, 90.7% contained a bla gene. The most common genotype was the blaCTX-M-1 group (49.8%); 1.8% were carbapenem-resistant Enterobacteriaceae (three blaKPC and one blaIMP). Overall, pAmpC (blaACT/MIR and blaCMY) were present in 14.2%. The predominant E. coli phylogenetic group was the virulent B2 group (67.6%) associated with ST43/ST131 (Pasteur/Achtman MLST scheme) containing the blaCTX-M-1 group (84%), and plasmid replicon types FIA, FII, and FIB. K. pneumoniae harboring blaKPC were non-ST258 with replicon types I1 and A/C. Enterobacter spp. carrying blaACT/MIR contained plasmid replicon FIIA. We found that β-lactam resistance in children is diverse and that certain resistance mechanisms differ from known circulating genotypes in adults in an endemic area. The potential impact of complex molecular types and the silent dissemination of MDR Enterobacteriaceae in a vulnerable population needs to be studied further.
在美国儿童中,多重耐药(MDR)肠杆菌科细菌感染正在增加;然而,对于儿科肠杆菌科细菌分离株中导致MDR表型的抗生素耐药基因,缺乏多中心分析。在本研究中,分析了2011年1月至2015年4月期间在芝加哥地区三家医院住院的0至18岁儿童中,225株表型鉴定为超广谱β-内酰胺酶(ESBL)或碳青霉烯酶产生菌的分离株。我们使用DNA微阵列平台检测ESBL、质粒介导的AmpC(pAmpC)和碳青霉烯酶型β-内酰胺酶(bla)基因。进行基于重复序列的PCR和多位点序列分型(MLST)以评估分离株的相似性。进行质粒复制子分型以对质粒进行分类。患者中位年龄为4.2岁,56%为女性,44%为门诊患者。大多数(60.9%)分离株为大肠埃希菌,且来自尿液来源(69.8%)。在225株表现出ESBL或碳青霉烯酶产生表型的分离株中,90.7%含有bla基因。最常见的基因型是blaCTX-M-1组(49.8%);1.8%为耐碳青霉烯肠杆菌科细菌(3株blaKPC和1株blaIMP)。总体而言,pAmpC(blaACT/MIR和blaCMY)存在于14.2%的分离株中。大肠埃希菌的主要系统发育组是与ST43/ST131(巴斯德/阿赫特曼MLST方案)相关的毒性B2组(67.6%),其中含有blaCTX-M-1组(84%),以及质粒复制子类型FIA、FII和FIB。携带blaKPC的肺炎克雷伯菌不是ST258,其复制子类型为I1和A/C。携带blaACT/MIR的肠杆菌属含有质粒复制子FIIA。我们发现儿童中的β-内酰胺耐药性具有多样性,并且在流行地区,某些耐药机制与成人中已知的流行基因型不同。MDR肠杆菌科细菌复杂分子类型的潜在影响以及在脆弱人群中的隐匿传播需要进一步研究。